Jingling Su

825 total citations
16 papers, 509 citations indexed

About

Jingling Su is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Jingling Su has authored 16 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Jingling Su's work include Inflammatory Bowel Disease (10 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Jingling Su is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Jingling Su collaborates with scholars based in China, Canada and United States. Jingling Su's co-authors include Zhanju Liu, Praveen Kumar Yadav, Junshan Wang, Fei Ke, Ping‐Chang Yang, Tengfei Chen, Jianlin Ren, Chi Chen, Maochun Tang and Changqin Liu and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Leukocyte Biology.

In The Last Decade

Jingling Su

16 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingling Su China 10 256 179 132 79 78 16 509
Esther Vogels Netherlands 9 205 0.8× 174 1.0× 140 1.1× 59 0.7× 83 1.1× 17 516
Heike Dornhoff Germany 6 425 1.7× 194 1.1× 89 0.7× 78 1.0× 73 0.9× 7 574
Riccardo G. Borroni Italy 15 183 0.7× 90 0.5× 114 0.9× 49 0.6× 226 2.9× 58 659
Weigang Shu China 8 142 0.6× 103 0.6× 147 1.1× 54 0.7× 59 0.8× 10 366
Martina Rocchi Italy 7 169 0.7× 67 0.4× 167 1.3× 37 0.5× 28 0.4× 11 398
Rut Mora‐Buch Spain 8 356 1.4× 231 1.3× 209 1.6× 91 1.2× 74 0.9× 13 710
Bi-Huei Yang United States 8 459 1.8× 120 0.7× 201 1.5× 114 1.4× 89 1.1× 13 730
Carole Smith Australia 7 224 0.9× 92 0.5× 56 0.4× 44 0.6× 61 0.8× 11 373
Annette Eyking Germany 9 188 0.7× 95 0.5× 320 2.4× 134 1.7× 39 0.5× 11 595
James A. Dromey Australia 12 328 1.3× 256 1.4× 117 0.9× 229 2.9× 215 2.8× 14 887

Countries citing papers authored by Jingling Su

Since Specialization
Citations

This map shows the geographic impact of Jingling Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingling Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingling Su more than expected).

Fields of papers citing papers by Jingling Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingling Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingling Su. The network helps show where Jingling Su may publish in the future.

Co-authorship network of co-authors of Jingling Su

This figure shows the co-authorship network connecting the top 25 collaborators of Jingling Su. A scholar is included among the top collaborators of Jingling Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingling Su. Jingling Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Yuanyuan, et al.. (2025). Correlation of serum trace elements with clinical features and gut microbiota in patients with Crohn's disease. The Journal of Nutritional Biochemistry. 142. 109917–109917. 1 indexed citations
2.
Su, Jingling, et al.. (2024). Class A1 scavenger receptor antibody improves murine colitis by influencing macrophage and gut microbiota. Scientific Reports. 14(1). 18618–18618. 2 indexed citations
3.
Chen, Qiongyun, Yanyun Fan, Bangzhou Zhang, et al.. (2023). Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis. Frontiers in Cellular and Infection Microbiology. 12. 1086885–1086885. 18 indexed citations
4.
Chen, Qiongyun, Yanyun Fan, Bangzhou Zhang, et al.. (2023). Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation. Microbiology Spectrum. 11(3). e0415222–e0415222. 26 indexed citations
5.
Gao, Han, Qiong He, Zhi Pang, et al.. (2022). The Development and Validation of Anti-paratuberculosis-nocardia Polypeptide Antibody [Anti-pTNP] for the Diagnosis of Crohn’s Disease. Journal of Crohn s and Colitis. 16(7). 1110–1123. 3 indexed citations
6.
Su, Jingling, et al.. (2022). Decreased serum iron concentration and total iron binding capacity are associated with serious Crohn’s disease. Scientific Reports. 12(1). 3923–3923. 1 indexed citations
7.
Ouyang, Hui, et al.. (2022). Increased modified DUBLIN scores are associated with serious ulcerative colitis and treatment failure. Therapeutic Advances in Gastroenterology. 15. 1098325647–1098325647. 2 indexed citations
8.
Fan, Yanyun, Yinshi Huang, Yiqun Hu, et al.. (2020). Class A1 scavenger receptors mediated macrophages in impaired intestinal barrier of inflammatory bowel disease. Annals of Translational Medicine. 8(4). 106–106. 11 indexed citations
9.
Su, Jingling, et al.. (2019). Synergistic effect of enteral nutrition on remission induction in a patient with penetrating Crohn disease. Medicine. 98(32). e16750–e16750. 3 indexed citations
10.
Su, Jingling, et al.. (2019). Elevated serum triglyceride and low-density lipoprotein cholesterol promotes the formation of colorectal polyps. BMC Gastroenterology. 19(1). 195–195. 26 indexed citations
11.
Su, Jingling, Yanyun Fan, Yiqun Hu, et al.. (2017). Interleukin-25 enhances the capacity of mesenchymal stem cells to induce intestinal epithelial cell regeneration.. PubMed. 9(12). 5320–5331. 10 indexed citations
12.
Su, Jingling, Yiqun Hu, Qingwen Huang, et al.. (2017). Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype.. PubMed. 9(9). 4149–4160. 32 indexed citations
13.
Su, Jingling, Tengfei Chen, Xin‐Ying Ji, et al.. (2013). IL-25 Downregulates Th1/Th17 Immune Response in an IL-10–Dependent Manner in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 19(4). 720–728. 86 indexed citations
14.
Liu, Zhanju, Bai–Sui Feng, Shaobo Yang, et al.. (2011). Interleukin (IL)-23 Suppresses IL-10 in Inflammatory Bowel Disease. Journal of Biological Chemistry. 287(5). 3591–3597. 44 indexed citations
15.
Liu, Zhanju, Praveen Kumar Yadav, Xiaorong Xu, et al.. (2011). The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. Journal of Leukocyte Biology. 89(4). 597–606. 121 indexed citations
16.
Liu, Zhanju, Praveen Kumar Yadav, Jingling Su, Junshan Wang, & Fei Ke. (2009). Potential role of Th17 cells in the pathogenesis ofinflammatory bowel disease. World Journal of Gastroenterology. 15(46). 5784–5784. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026